Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoichi Naito

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 13, 2017
[The Role of Novel Agents in the Treatment of Soft Tissue Sarcoma]Yoichi Naito
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 17, 2022
[Ⅰ. TRK Inhibitors for NTRK Fusion-Positive Soft Tissue Sarcoma]Yoichi Naito
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 4, 2026
[BRAF-Mutant Solid Tumor]Yoichi Naito
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 16, 2021
[Ⅱ. Application for HER2-Positive Breast Cancer(Trastuzumab Deruxtecan)]Yoichi Naito
Chinese Clinical Oncology|July 31, 2018
Precision medicine in breast cancerYoichi Naito, Tetsuya Urasaki
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 12, 2013
[Novel molecular-targeted agents for GIST(Regorafenib etc.)]Yoichi Naito, Toshihiko Doi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 25, 2022
[NTRK Gene Fusions and Treatment in NTRK Fusion-Positive Solid Cancers]Misao Fukuda, Yoichi Naito
The New England Journal of Medicine|December 15, 2010
Neoadjuvant chemotherapy or primary surgery in advanced ovarian cancerYoichi Naito, Yuji Miura, Toshimi Takano
Japanese Journal of Clinical Oncology|May 1, 2010
Elderly breast cancer therapy: a Japanese experienceYoichi Naito, Hirofumi Mukai, Shunji Nagai
Expert Opinion on Pharmacotherapy|July 4, 2014
Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumorsToshirou Nishida, Toshihiko Doi, Yoichi Naito
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 13, 2017
[The Role of Novel Agents in the Treatment of Soft Tissue Sarcoma]Yoichi Naito
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 17, 2022
[Ⅰ. TRK Inhibitors for NTRK Fusion-Positive Soft Tissue Sarcoma]Yoichi Naito
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 4, 2026
[BRAF-Mutant Solid Tumor]Yoichi Naito
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 16, 2021
[Ⅱ. Application for HER2-Positive Breast Cancer(Trastuzumab Deruxtecan)]Yoichi Naito
Chinese Clinical Oncology|July 31, 2018
Precision medicine in breast cancerYoichi Naito, Tetsuya Urasaki
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 12, 2013
[Novel molecular-targeted agents for GIST(Regorafenib etc.)]Yoichi Naito, Toshihiko Doi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 25, 2022
[NTRK Gene Fusions and Treatment in NTRK Fusion-Positive Solid Cancers]Misao Fukuda, Yoichi Naito
The New England Journal of Medicine|December 15, 2010
Neoadjuvant chemotherapy or primary surgery in advanced ovarian cancerYoichi Naito, Yuji Miura, Toshimi Takano
Japanese Journal of Clinical Oncology|May 1, 2010
Elderly breast cancer therapy: a Japanese experienceYoichi Naito, Hirofumi Mukai, Shunji Nagai
Expert Opinion on Pharmacotherapy|July 4, 2014
Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumorsToshirou Nishida, Toshihiko Doi, Yoichi Naito
Pageof 16